PubMed · 16506613
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
Bernard Touati, Eric Rompen, Eric Van Dooren. A new concept for optimizing soft tissue integration.. https://pubmed.ncbi.nlm.nih.gov/16506613/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
To compare the accuracy of cone beam CT scanning (NewTom 3G) with intraoral periapical radiography (Dixi2, Planmeca CCD sensor and Insight film) for the detection of periapical bone defects. Ten frozen pig mandibles were used. All soft tissues were removed and the jaws were sagittally sectioned to obtain three blocks from each side of the jaw containing the premolars and the molars with surrounding jaw bone. All teeth with intact roots were then "extracted". First, 15 blocks were used to define defect size and exposure parameters; then, the remaining 45 blocks were divided into three equal groups. In one group, cylindrical defects of 1 x 1 mm were prepared beyond the apices of the extraction sockets, in another group defects of 2 x 2 mm were similarly prepared, while no defects were prepared in the last group. The teeth were replaced into their sockets and digital and conventional radiographs of all blocks were taken under reproducible conditions. In addition, all blocks were CT scanned with the same volumetric data and then reconstructed to provide sagittal and coronal 2-D sections. Masked evaluation of the images (defect present vs no defect) was performed by four calibrated examiners. Statistical analysis was performed with ANOVA and the significance level was set to P < 0.05. NewTom 3G was statistically significantly better in terms of sensitivity (54%), positive (82.6%) and negative (44.5%) predictive values, and diagnostic accuracy (61%) when compared with digital radiographs (23%, 60%, 31%, 39%), and with conventional ones (28%, 70%, 35%, 44%)-except in the positive predictive value. Specificity was similar for all three methods. No difference was observed between the two periapical (digital vs conventional) radiographs. NewTom 3G may be useful in cases of immediate implants intended to replace teeth with suspicion for possible existing endodontic pathology, or in candidate implant sites neighboring such teeth.
In the oral microbial environment, Gram-negative bacterial derived lipopolysaccharide (LPS) can initiate inflammatory bone loss as seen in periodontal diseases. p38 Mitogen-activated protein kinase (MAPK) signaling is critical to inflammatory cytokine and LPS-induced cytokine expression, which may contribute toward periodontal bone loss. The purpose of this proof-of-principle study was to evaluate the ability of an orally active p38alpha MAPK inhibitor (SD-282) to reduce periopathogenic LPS-induced alveolar bone loss in an experimental rat model. Five groups of Sprague-Dawley rats received one of the following treatments: LPS injected to the palatal gingiva adjacent to the maxillary molars three times per week for 8 weeks, LPS plus two doses of SD-282 (15 or 45 mg/kg) twice daily by oral gavage, or control groups given drug vehicle (1% polyethylene glycol) or SD-282 (45 mg/kg) only. Baseline and 8-week alveolar bone loss was assessed by microcomputed tomography (microCT) and histological examination. LPS induced severe bone loss over this time period, whereas control groups were unchanged from baseline measurements. Both doses of SD-282 showed significant protection from LPS-induced bone loss. Bone area and volumetric analysis of maxillas by microCT indicated significant loss of bone volume with LPS treatment, which was blocked with the p38 inhibitor. Histological examination indicated significantly fewer tartate-resistant acid phosphatase-positive osteoclasts and a significant decrease in interleukin (IL)-6, IL-1beta, and tumor necrosis factor alpha expression in p38 inhibitor-treated groups compared with LPS groups by immunostaining. Results from this in vivo study suggest that orally active p38 MAPK inhibitors can reduce LPS-induced inflammatory cytokine production and osteoclast formation and protect against LPS-stimulated alveolar bone loss.
OBJECTIVE: Novel implant technologies and reconstructive therapies for alveolar augmentation require pre-clinical evaluation to estimate their biologic potential, efficacy, and safety before clinical application. The objective of this report is to present characteristics and use of the critical-size, supraalveolar, peri-implant defect model. METHODS: Bilateral extraction of the mandibular premolars was performed in 12 Hound Labrador mongrel dogs following horizontal surgical cut-down of the alveolar ridge approximating 6 mm. Each jaw quadrant received three custom-produced TiUnite, phi 4.0 x 10 mm threaded implants placed into osteotomies prepared into the extraction sites of the third and fourth premolars. The implants exhibited a reference notch 5 mm from the implant platform to facilitate surgical placement leaving 5 mm of the implant in a supraalveolar position, and to serve as a reference point in the radiographic, histologic and histometric analysis. The implants were submerged under the mucoperiosteal flaps for primary intention healing. Fluorescent bone markers were administered at weeks 3 and 4 post-surgery, and pre-euthanasia. The animals were euthanized following an 8-week healing interval when block biopsies were collected for analysis. RESULTS: Healing was generally uneventful. The radiographic and histometric evaluations demonstrate the limited osteogenic potential of this defect model. Whereas lingual peri-implant sites exhibited a mean (+/-SE) bone gain of 0.4+/-0.1 mm, resorption of the buccal crestal plate resulted in a mean bone loss of 0.4+/-0.2 mm for an overall osteogenic potential following sham-surgery averaging 0.0+/-0.1 mm. Overall bone density and bone-implant contact in the contiguous resident bone averaged 79.1+/-1.1% and 76.9+/-2.3%, respectively. CONCLUSION: The results suggest that the critical-size, supraalveolar, peri-implant defect model appears a rigorous tool in the evaluation of candidate technologies for alveolar reconstruction and osseointegration of endosseous oral implants. Limited innate osteogenic potential allows critical evaluation of osteogenic, osteoconductive, or osteoinductive technologies in a challenging clinical setting.